Funding · Company
Solve Therapeutics, Inc.
Belmont, CABiotech & Pharma
Solve Therapeutics, Inc. of Belmont, CA has disclosed $162M across 3 Form D offerings filed with the SEC between Jan 21, 2022 and Nov 25, 2025.
$162M
Total disclosed
3
Form D offerings
2021
Incorporated
Offerings on file
Each amount is as reported on that filing, cumulative across its own amendments. Newest first.
$48M
Form D · Nov 25, 2025 ↗
Q4 2025
· target $121M
$50M
Form D · Dec 26, 2024 ↗
Q4 2024
· target $76M
$64M
Form D · Jan 21, 2022 ↗
Q1 2022
· target $127M
Filing details
HeadquartersBelmont, CAIndustryBiotech & Pharma (Biotechnology)Incorporated2021SEC CIK0001905252Offerings on file3
Source: SEC Form D structured data. Amounts are self-reported by the issuer on a notice filing — not audited, and cumulative across amendments. The website link is resolved automatically and may be wrong — tell us if it is. Full methodology →